Health & Fitness

Understanding how brain areas communicate is one of the oldest questions in neuroscience. Researchers used causal techniques to uncover how two neocortical areas in the brain communicate with one another and found that their influence on each other changes over much faster-timescales than previously thought.

from Top Health News -- ScienceDaily https://ift.tt/rsU2pAo

Transition to middle school can be a stressful time for adolescents. They must adjust to a new peer group and social environment while going through the developmental changes of puberty. A recent study looks at how emotional aspects of parenting can help youth better cope with peer stressors during this transitional period.

from Top Health News -- ScienceDaily https://ift.tt/2DRWhMO

Heart failure patients who are unvaccinated against SARS-CoV-2, the virus that causes COVID-19, are three times more likely to die if infected with the virus compared to fully boosted heart failure patients, according to new research.

from Top Health News -- ScienceDaily https://ift.tt/TXY1ypL

Moderate average drinkers with a pattern of binge drinking were almost five times more likely to experience multiple alcohol problems, researchers report.

from Top Health News -- ScienceDaily https://ift.tt/5w7Do06

People with certain inflammatory immune conditions affecting the joints, bowel and skin, such as rheumatoid arthritis, may have been more at risk of dying or needing hospital care if they got COVID-19 before vaccination compared with the general population, according to a new study.

from Top Health News -- ScienceDaily https://ift.tt/LHXWKao

An inhaled immunotherapy successfully treated cancer in some companion dogs as part of a clinical trial conducted by oncology and veterinary researchers. Results show potential for fighting cancer in humans as well.

from Top Health News -- ScienceDaily https://ift.tt/D2jrAgv

A drug currently used in just 1% of cancers has significant potential against the remaining 99%, according to a new study. Ivosidenib, or AG-120, is currently used against cancers that have a mutation in the IDH1 gene. However, study results show that Ivosidenib is also effective against unmutated, or 'wild-type' IDH1. The protein coded by the IDH1 gene in cancers helps cancer cells survive in a stressful tumor environment, so any inhibitor medication that could weaken this defense mechanism is considered a promising therapy.

from Top Health News -- ScienceDaily https://ift.tt/1PkxgS7